OpenNashEarnings

Altria (MO) · Consumer Brands

Altria Q2 2026 earnings: summary, key numbers & outlook

Results filed 30 Jul 2026 · Quarter ended 30 Jun 2026

Press release ↗Investor relations ↗

Summaries and transcripts are machine-generated and can contain errors.

In brief

Altria resumed on! PLUS shipments in three states, plans national expansion in the third quarter, and will add new flavors in the fourth as it builds out its smoke-free portfolio.

Altria's smoke-free push centered on Helix's on! PLUS pouches, now in 120,000 stores, with shipments of the 12-milligram version resuming in Florida, North Carolina and Texas. Marlboro Cowboy Cut drew strong interest among premium smokers and Basic gained traction in discount. Adult smokers keep trading down: discount brands reached 33.8% of the cigarette industry, and the nicotine pouch category grew to 59.9% of oral tobacco.

Management is steering toward a national on! PLUS rollout, new flavors and strengths, and a broader Vision of growth beyond the U.S. and beyond nicotine. Capital spending is rising to consolidate USSTC manufacturing and to support contract manufacturing. The main tension is that cigarette volumes keep falling, MST is losing share, NJOY ACE stays off the market in 2026, and consumers face economic pressure.

Key numbers

Net revenues · GAAP
$6.1B

0.1% vs. Q2 2025

Net earnings · GAAP
$2.3B

(3.4)% vs. Q2 2025

Reported diluted EPS · GAAP
$1.37

down 2.8% from a year ago

Adjusted diluted EPS · non-GAAP
$1.48

up 2.8% from a year ago

Operating income · GAAP
$3.1B

(2.9)% vs. Q2 2025

Segment or metricValueChange
Smokeable products net revenues$5.4B0.7%
Oral tobacco products net revenues$713.0M(5.3)%
Smokeable products adjusted OCI$3.0B2.4%
Oral tobacco products adjusted OCI$460.0M(8.0)%
Marlboro retail share of total cigarette category39.5%decrease of 1.5 share points
on! retail share of nicotine pouch category14.4%decrease of 1.7 share points
Domestic cigarette shipment volume15.6B(3.2)%
Where each number comes from
  • Net revenues: “Altria Headline Financials 1 ($ in millions, except per share data) | Q2 2026 | Change vs. Q2 2025 | First Half 2026 | Change vs. First Half 2025 Net revenues | $6,111 | 0.1%”
  • Net earnings: “Provision for income taxes | 631 | 740 Net earnings | $2,298 | $2,378 | (3.4)% Per share data: Diluted earnings per share | $1.37 | $1.41 | (2.8)%”
  • Reported diluted EPS: “Reported diluted EPS decreased 2.8% to $1.37, primarily driven by lower OCI (including higher tobacco and health and certain other litigation items and 2026 costs related to the USSTC Facilities Consolidation)”
  • Adjusted diluted EPS: “Adjusted diluted EPS increased 2.8% to $1.48, primarily driven by higher adjusted OCI and fewer shares outstanding.”
  • Operating income: “Amortization of intangibles | 23 | 37 General corporate expenses | 87 | 53 Operating income | 3,136 | 3,230 | (2.9)%”
  • Smokeable products net revenues: “Net revenues | $5,392 | $5,357 | 0.7% | $10,150 | $9,979 | 1.7% Excise taxes | (732) | (787)”
  • Oral tobacco products net revenues: “Table 5 - Oral Tobacco Products: Revenues and OCI ($ in millions) Second Quarter | Six Months Ended June 30, 2026 | 2025 | Change | 2026 | 2025 | Change Net revenues | $713 | $753 | (5.3)%”
  • Smokeable products adjusted OCI: “Tobacco and health and certain other litigation items | 67 | 4 | 69 | 40 Adjusted OCI | $3,018 | $2,947 | 2.4% | $5,694 | $5,465 | 4.2%”
  • Oral tobacco products adjusted OCI: “Asset impairment, exit and implementation costs | 79 | 2 | 80 | 4 Adjusted OCI | $460 | $500 | (8.0)% | $896 | $935 | (4.2)%”
  • Marlboro retail share of total cigarette category: “Marlboro retail share of the total cigarette category was 39.5%, a decrease of 1.5 share points versus the prior year and 0.2 share points sequentially.”
  • on! retail share of nicotine pouch category: “on! retail share of the nicotine pouch category was 14.4%, a decrease of 1.7 share points versus the prior year and an increase of 1.0 share point sequentially.”
  • Domestic cigarette shipment volume: “Total domestic cigarettes 1 | 15,554 | 16,066 | (3.2)% | 29,421 | 30,270 | (2.8)%”

Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.

From the filingQ2 2026vs year agovs last quarter
Revenue$6.1B+0.1%+12.6%
Operating income$3.1B−2.9%+6.1%
Net income$2.3B−3.4%+5.3%
Diluted EPS$1.37−2.8%+5.4%
Free cash flow$662.0M+282.7%−70.3%
Gross margin62.5%−0.6 pts−2.1 pts
Operating margin51.3%−1.6 pts−3.2 pts

Calculated by code from XBRL, not by the model.

Outlook

MetricPeriodOutlook
Adjusted diluted EPSfull-year 2026$5.61 to $5.72
Capital expenditures2026$375 million and $450 million

Key takeaways

  1. on! PLUS is being relaunched nationally

    Helix resumed 12-milligram on! PLUS shipments in Florida, North Carolina and Texas, with national expansion planned for the third quarter. It matters because nicotine pouches are now 59.9% of the oral category.

  2. New on! PLUS flavors and strengths arrive in Q4

    Helix plans additional flavors across 6-, 9- and 12-milligram strengths, starting with Blueberry Mint and Mango Pineapple. This widens the range as on! competes for pouch share.

  3. Smokers are trading down to discount brands

    Discount reached 33.8% of industry cigarette share, up 2.6 points, and Altria's own discount shipments rose 67.3%. Marlboro Cowboy Cut and Basic are PM USA's responses across premium and discount.

  4. MST share losses weigh on oral tobacco

    Copenhagen and Skoal lost share while pouches grew, and oral shipments fell 8.5%. Altria depends on on! to offset the decline of its traditional oral franchises.

  5. Manufacturing investment is rising and NJOY ACE stays out

    Capital expenditure guidance rose to support USSTC Facilities Consolidation, and Altria is investing in contract manufacturing, with contract-manufactured export cigarette volume up 54.9%. NJOY ACE is not expected back in 2026.

Charts

Revenue$6.1B+0.1% y/yQ2 2026
Q4 2024: $6.0B (worked out from the annual figure)Q4 ’24$6.0BQ1 2025: $5.3BQ1 ’25$5.3BQ2 2025: $6.1BQ2 ’25$6.1BQ3 2025: $6.1BQ3 ’25$6.1BQ4 2025: $5.8B (worked out from the annual figure)Q4 ’25$5.8BQ1 2026: $5.4BQ1 ’26$5.4BQ2 2026: $6.1BQ2 ’26$6.1BQ3 2026: $6.1BQ3 ’26$6.1B

Fourth quarter worked out from the annual figure.

Data
Q4 2024$6.0B *
Q1 2025$5.3B
Q2 2025$6.1B
Q3 2025$6.1B
Q4 2025$5.8B *
Q1 2026$5.4B
Q2 2026$6.1B
Q3 2026$6.1B
Diluted EPS (GAAP)$1.37−2.8% y/yQ2 2026
Q1 2025: $0.63Q1 ’25$0.63Q2 2025: $1.41Q2 ’25$1.41Q3 2025: $1.41Q3 ’25$1.41Q1 2026: $1.30Q1 ’26$1.30Q2 2026: $1.37Q2 ’26$1.37Q3 2026: $1.51Q3 ’26$1.51
Data
Q1 2025$0.63
Q2 2025$1.41
Q3 2025$1.41
Q1 2026$1.30
Q2 2026$1.37
Q3 2026$1.51

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Operating margin51.3%−1.6 pts y/yQ2 2026
Q4 2024: 48.2%Q4 ’2448.2%Q1 2025: 34.0%Q1 ’2534.0%Q2 2025: 52.9%Q2 ’2552.9%Q3 2025: 53.2%Q3 ’2553.2%Q4 2025: 28.2%Q4 ’2528.2%Q1 2026: 54.5%Q1 ’2654.5%Q2 2026: 51.3%Q2 ’2651.3%Q3 2026: 54.0%Q3 ’2654.0%
Data
Q4 202448.2%
Q1 202534.0%
Q2 202552.9%
Q3 202553.2%
Q4 202528.2%
Q1 202654.5%
Q2 202651.3%
Q3 202654.0%
Free cash flow$662.0M+282.7% y/yQ2 2026
Q4 2024: $3.3BQ4 ’24$3.3BQ1 2025: $2.7BQ1 ’25$2.7BQ2 2025: $173.0MQ2 ’25$173.0MQ3 2025: $3.0BQ3 ’25$3.0BQ4 2025: $3.2BQ4 ’25$3.2BQ1 2026: $2.2BQ1 ’26$2.2BQ2 2026: $662.0MQ2 ’26$662.0MQ3 2026: $3.0BQ3 ’26$3.0B
Data
Q4 2024$3.3B
Q1 2025$2.7B
Q2 2025$173.0M
Q3 2025$3.0B
Q4 2025$3.2B
Q1 2026$2.2B
Q2 2026$662.0M
Q3 2026$3.0B

Operating cash flow minus capital expenditure, from cash flow statements.

Questions

What is Altria doing with on! PLUS?

Helix resumed 12-milligram shipments in Florida, North Carolina and Texas, plans national expansion in the third quarter, and will add flavors such as Blueberry Mint and Mango Pineapple in the fourth quarter.

How is Altria's cigarette business responding to consumer pressure?

PM USA is pursuing a data-driven, total portfolio approach, with Marlboro Cowboy Cut for premium smokers and Basic in discount, as industry discount share rose 2.6 points to 33.8%.

How is on! performing against competitors in nicotine pouches?

on! held 14.4% of the pouch category, down 1.7 points from a year ago but up 1.0 point sequentially, in a category that now makes up 59.9% of oral tobacco.

What is happening with NJOY and e-vapor?

Altria's guidance assumes NJOY ACE does not return to the market in 2026, and it cites moderated e-vapor industry growth as a factor affecting combustible and e-vapor volumes.

Why did Altria raise capital spending plans?

Expected 2026 capital expenditures rose to $375 million to $450 million from $300 million to $375 million, primarily to support consolidating USSTC's manufacturing operations.

Documents

SEC filing